Search research articles
Contact Us
Filters
Showing results (1-10 of 30) with videos related to
Page
of 3
Sort By:
Leukemia Research
|
December 18, 2007
Response of primary plasma cell leukemia to the combination of bortezomib and dexamethasone: do specific cytogenetic and immunophenotypic characteristics influence treatment outcome?
Eirini Katodritou, Evgenia Verrou, Vassiliki Gastari, et al.
Leukemia Research
|
July 6, 2006
Bortezomib is an effective agent for MDS/MPD syndrome with 5q- anomaly and thrombocytosis
Evangelos Terpos, Evgenia Verrou, Anastasia Banti, et al.
British Journal of Haematology
|
August 8, 2006
Incidence, risk factors and management of osteonecrosis of the jaw in patients with multiple myeloma: a single-centre experience in 303 patients
Kostas Zervas, Evgenia Verrou, Zisis Teleioudis, et al.
Frontiers in Genetics
|
April 29, 2024
HLA variations in patients with diffuse large B-cell lymphoma and association with disease risk and prognosis: a case-control study
Ioanna Diamanti, Asimina Fylaktou, Evgenia Verrou, et al.
Leukemia Research Reports
|
August 17, 2021
Chronic myelogenous leukemia occurring in two brothers: The opposite sides of the same coin?
Evgenia Verrou, Kyriaki Tsirou, Nikolaos Karampatzakis, et al.
Annals of Hematology
|
March 22, 2007
Hypochromic erythrocytes (%): a reliable marker for recognizing iron-restricted erythropoiesis and predicting response to erythropoietin in anemic patients with myeloma and lymphoma
Eirini Katodritou, Evangelos Terpos, Konstantinos Zervas, et al.
American Journal of Hematology
|
July 16, 2008
Erythropoiesis-stimulating agents are associated with reduced survival in patients with multiple myeloma
Eirini Katodritou, Evgenia Verrou, Christina Hadjiaggelidou, et al.
Leukemia Research
|
June 15, 2007
Successful treatment of extramedullary gastric plasmacytoma with the combination of bortezomib and dexamethasone: first reported case
Eirini Katodritou, Charalambos Kartsios, Vassiliki Gastari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 20, 2008
Natural history of osteonecrosis of the jaw in patients with multiple myeloma
Ashraf Badros, Evangelos Terpos, Eirini Katodritou, et al.
Annals of Hematology
|
March 22, 2019
Evaluation of regulatory T cells (Tregs) alterations in patients with multiple myeloma treated with bortezomib or lenalidomide plus dexamethasone: correlations with treatment outcome
Christina Hadjiaggelidou, Evdokia Mandala, Evangelos Terpos, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 30) with videos related to
Sort By:
Page
of 3
Leukemia Research
|
December 18, 2007
Response of primary plasma cell leukemia to the combination of bortezomib and dexamethasone: do specific cytogenetic and immunophenotypic characteristics influence treatment outcome?
Eirini Katodritou, Evgenia Verrou, Vassiliki Gastari, et al.
Leukemia Research
|
July 6, 2006
Bortezomib is an effective agent for MDS/MPD syndrome with 5q- anomaly and thrombocytosis
Evangelos Terpos, Evgenia Verrou, Anastasia Banti, et al.
British Journal of Haematology
|
August 8, 2006
Incidence, risk factors and management of osteonecrosis of the jaw in patients with multiple myeloma: a single-centre experience in 303 patients
Kostas Zervas, Evgenia Verrou, Zisis Teleioudis, et al.
Frontiers in Genetics
|
April 29, 2024
HLA variations in patients with diffuse large B-cell lymphoma and association with disease risk and prognosis: a case-control study
Ioanna Diamanti, Asimina Fylaktou, Evgenia Verrou, et al.
Leukemia Research Reports
|
August 17, 2021
Chronic myelogenous leukemia occurring in two brothers: The opposite sides of the same coin?
Evgenia Verrou, Kyriaki Tsirou, Nikolaos Karampatzakis, et al.
Annals of Hematology
|
March 22, 2007
Hypochromic erythrocytes (%): a reliable marker for recognizing iron-restricted erythropoiesis and predicting response to erythropoietin in anemic patients with myeloma and lymphoma
Eirini Katodritou, Evangelos Terpos, Konstantinos Zervas, et al.
American Journal of Hematology
|
July 16, 2008
Erythropoiesis-stimulating agents are associated with reduced survival in patients with multiple myeloma
Eirini Katodritou, Evgenia Verrou, Christina Hadjiaggelidou, et al.
Leukemia Research
|
June 15, 2007
Successful treatment of extramedullary gastric plasmacytoma with the combination of bortezomib and dexamethasone: first reported case
Eirini Katodritou, Charalambos Kartsios, Vassiliki Gastari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 20, 2008
Natural history of osteonecrosis of the jaw in patients with multiple myeloma
Ashraf Badros, Evangelos Terpos, Eirini Katodritou, et al.
Annals of Hematology
|
March 22, 2019
Evaluation of regulatory T cells (Tregs) alterations in patients with multiple myeloma treated with bortezomib or lenalidomide plus dexamethasone: correlations with treatment outcome
Christina Hadjiaggelidou, Evdokia Mandala, Evangelos Terpos, et al.
Page
of 3